| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Telomere | 39 | 2021 | 546 | 2.840 |
Why?
|
| In Situ Hybridization, Fluorescence | 27 | 2018 | 2312 | 0.740 |
Why?
|
| Chromosomal Instability | 11 | 2024 | 228 | 0.720 |
Why?
|
| Genomic Instability | 16 | 2022 | 518 | 0.620 |
Why?
|
| Chromosome Aberrations | 21 | 2021 | 2035 | 0.590 |
Why?
|
| Cyclin E | 5 | 2024 | 284 | 0.570 |
Why?
|
| Aneuploidy | 5 | 2024 | 382 | 0.540 |
Why?
|
| Tumor Cells, Cultured | 31 | 2020 | 5759 | 0.490 |
Why?
|
| Epithelial Cells | 7 | 2024 | 1874 | 0.470 |
Why?
|
| Telomerase | 10 | 2021 | 544 | 0.460 |
Why?
|
| DNA, Neoplasm | 9 | 2018 | 1958 | 0.460 |
Why?
|
| Gene Amplification | 7 | 2019 | 764 | 0.460 |
Why?
|
| Cytogenetic Analysis | 6 | 2020 | 574 | 0.430 |
Why?
|
| DNA-Binding Proteins | 15 | 2021 | 4992 | 0.430 |
Why?
|
| Mice | 64 | 2024 | 35421 | 0.430 |
Why?
|
| Chromosomes | 9 | 2022 | 325 | 0.420 |
Why?
|
| Evolution, Molecular | 4 | 2022 | 866 | 0.420 |
Why?
|
| Animals | 79 | 2024 | 61357 | 0.420 |
Why?
|
| Neoplasm Transplantation | 11 | 2016 | 1553 | 0.410 |
Why?
|
| Melanoma, Experimental | 7 | 2003 | 381 | 0.410 |
Why?
|
| Tumor Suppressor Protein p53 | 16 | 2024 | 3656 | 0.390 |
Why?
|
| Heterochromatin | 3 | 2021 | 89 | 0.380 |
Why?
|
| DNA Repair | 9 | 2024 | 1906 | 0.380 |
Why?
|
| Recombination, Genetic | 7 | 2022 | 649 | 0.380 |
Why?
|
| DNA | 7 | 2024 | 3041 | 0.370 |
Why?
|
| DNA Damage | 11 | 2022 | 1991 | 0.350 |
Why?
|
| Apoptosis | 24 | 2024 | 7755 | 0.350 |
Why?
|
| Clone Cells | 7 | 2024 | 589 | 0.340 |
Why?
|
| Breast Neoplasms | 19 | 2024 | 16244 | 0.330 |
Why?
|
| Cell Proliferation | 12 | 2024 | 7232 | 0.320 |
Why?
|
| Prostatic Neoplasms | 14 | 2019 | 5869 | 0.310 |
Why?
|
| Cell Line, Tumor | 32 | 2024 | 14878 | 0.310 |
Why?
|
| Cell Transformation, Neoplastic | 11 | 2016 | 2454 | 0.310 |
Why?
|
| Cellular Senescence | 8 | 2009 | 389 | 0.300 |
Why?
|
| Mice, Nude | 19 | 2020 | 4332 | 0.300 |
Why?
|
| RNA, Long Noncoding | 3 | 2020 | 617 | 0.290 |
Why?
|
| Karyotyping | 16 | 2008 | 1064 | 0.290 |
Why?
|
| RecQ Helicases | 2 | 2007 | 97 | 0.290 |
Why?
|
| Mitosis | 9 | 2021 | 681 | 0.280 |
Why?
|
| Neoplastic Stem Cells | 3 | 2017 | 1456 | 0.280 |
Why?
|
| Paclitaxel | 3 | 1999 | 2114 | 0.270 |
Why?
|
| Genome | 3 | 2022 | 689 | 0.270 |
Why?
|
| Haploinsufficiency | 3 | 2016 | 301 | 0.260 |
Why?
|
| CDC2 Protein Kinase | 3 | 2024 | 188 | 0.260 |
Why?
|
| Prostate | 6 | 2019 | 1090 | 0.260 |
Why?
|
| Glioblastoma | 5 | 2019 | 1778 | 0.260 |
Why?
|
| Fibroblasts | 7 | 2016 | 1647 | 0.250 |
Why?
|
| Gene Expression Regulation, Neoplastic | 19 | 2020 | 9048 | 0.240 |
Why?
|
| Single-Cell Analysis | 3 | 2024 | 560 | 0.230 |
Why?
|
| Receptors, Purinergic P1 | 2 | 2001 | 29 | 0.230 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 1999 | 898 | 0.230 |
Why?
|
| Cell Lineage | 2 | 2024 | 697 | 0.230 |
Why?
|
| Triple Negative Breast Neoplasms | 4 | 2024 | 1385 | 0.220 |
Why?
|
| Caspases | 5 | 2004 | 672 | 0.220 |
Why?
|
| Humans | 99 | 2024 | 270713 | 0.220 |
Why?
|
| Drug Resistance, Neoplasm | 8 | 2024 | 5417 | 0.220 |
Why?
|
| Adrenal Cortex | 1 | 2022 | 37 | 0.210 |
Why?
|
| Neoplasms, Experimental | 4 | 2020 | 784 | 0.210 |
Why?
|
| Cell Nucleus | 6 | 2021 | 1715 | 0.210 |
Why?
|
| Adrenocortical Adenoma | 1 | 2022 | 24 | 0.210 |
Why?
|
| Y Chromosome | 2 | 2001 | 78 | 0.210 |
Why?
|
| Cells, Cultured | 12 | 2017 | 5657 | 0.210 |
Why?
|
| Cell Line | 9 | 2022 | 5313 | 0.210 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 4 | 2008 | 508 | 0.200 |
Why?
|
| Mesoderm | 2 | 2019 | 391 | 0.200 |
Why?
|
| Cell Culture Techniques | 4 | 2008 | 573 | 0.200 |
Why?
|
| Hominidae | 1 | 2022 | 43 | 0.200 |
Why?
|
| Cell Cycle | 9 | 2012 | 2134 | 0.200 |
Why?
|
| Receptor, ErbB-2 | 3 | 2024 | 2658 | 0.200 |
Why?
|
| DNA Replication | 3 | 2022 | 768 | 0.200 |
Why?
|
| DNA Copy Number Variations | 5 | 2024 | 1576 | 0.200 |
Why?
|
| Lymphoma | 4 | 2011 | 1516 | 0.200 |
Why?
|
| Neoplasm Proteins | 6 | 2016 | 3345 | 0.190 |
Why?
|
| Cytidine Deaminase | 1 | 2021 | 84 | 0.190 |
Why?
|
| Breast | 2 | 2024 | 1370 | 0.190 |
Why?
|
| Trastuzumab | 1 | 2024 | 743 | 0.190 |
Why?
|
| Eukaryota | 1 | 2021 | 28 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 6 | 2015 | 1544 | 0.190 |
Why?
|
| Cytogenetics | 2 | 2013 | 152 | 0.190 |
Why?
|
| Immunoconjugates | 1 | 2024 | 316 | 0.180 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2000 | 92 | 0.180 |
Why?
|
| Mammals | 2 | 2022 | 365 | 0.170 |
Why?
|
| Brain Neoplasms | 5 | 2019 | 4968 | 0.170 |
Why?
|
| SMARCB1 Protein | 1 | 2020 | 107 | 0.170 |
Why?
|
| Biological Evolution | 1 | 2021 | 289 | 0.170 |
Why?
|
| Interphase | 4 | 2021 | 156 | 0.170 |
Why?
|
| Cell Cycle Proteins | 8 | 2011 | 2112 | 0.170 |
Why?
|
| Chromosome Disorders | 4 | 1998 | 420 | 0.170 |
Why?
|
| BRCA2 Protein | 2 | 2013 | 380 | 0.160 |
Why?
|
| Primary Myelofibrosis | 2 | 2019 | 914 | 0.160 |
Why?
|
| Adenosine | 2 | 2001 | 293 | 0.160 |
Why?
|
| Tumor Suppressor Proteins | 5 | 2015 | 1901 | 0.160 |
Why?
|
| Multiprotein Complexes | 1 | 2021 | 380 | 0.160 |
Why?
|
| Zidovudine | 1 | 1998 | 43 | 0.160 |
Why?
|
| Species Specificity | 5 | 2001 | 783 | 0.160 |
Why?
|
| Carrier Proteins | 2 | 2017 | 2085 | 0.160 |
Why?
|
| Adenosine Triphosphatases | 1 | 2021 | 428 | 0.160 |
Why?
|
| Telomere-Binding Proteins | 5 | 2012 | 91 | 0.160 |
Why?
|
| Transplantation, Heterologous | 6 | 2019 | 1051 | 0.160 |
Why?
|
| Virus Integration | 1 | 2018 | 73 | 0.160 |
Why?
|
| Osteolysis | 1 | 2019 | 99 | 0.150 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 1 | 2018 | 57 | 0.150 |
Why?
|
| Bone Remodeling | 1 | 2019 | 100 | 0.150 |
Why?
|
| Ribonucleoproteins | 2 | 2015 | 116 | 0.150 |
Why?
|
| Carcinoma, Medullary | 1 | 2020 | 248 | 0.150 |
Why?
|
| Bone Marrow Transplantation | 2 | 2016 | 1754 | 0.150 |
Why?
|
| Polyploidy | 5 | 2011 | 76 | 0.150 |
Why?
|
| Neoplasms | 8 | 2024 | 15949 | 0.150 |
Why?
|
| Osteoclasts | 1 | 2019 | 160 | 0.150 |
Why?
|
| Stromal Cells | 3 | 2019 | 823 | 0.150 |
Why?
|
| Capsid | 1 | 2018 | 177 | 0.150 |
Why?
|
| Colorectal Neoplasms | 4 | 2020 | 3707 | 0.150 |
Why?
|
| Werner Syndrome | 3 | 2007 | 12 | 0.150 |
Why?
|
| Phthalazines | 1 | 2019 | 262 | 0.150 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1999 | 469 | 0.150 |
Why?
|
| DNA Breaks, Double-Stranded | 4 | 2017 | 327 | 0.140 |
Why?
|
| Chromosome Banding | 8 | 2002 | 280 | 0.140 |
Why?
|
| Translocation, Genetic | 5 | 2013 | 1286 | 0.140 |
Why?
|
| Graft Rejection | 1 | 2001 | 844 | 0.140 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2020 | 2386 | 0.140 |
Why?
|
| Myelodysplastic-Myeloproliferative Diseases | 1 | 2018 | 120 | 0.140 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2021 | 358 | 0.140 |
Why?
|
| Ichthyosis | 1 | 1996 | 22 | 0.140 |
Why?
|
| Biomarkers, Tumor | 6 | 2022 | 10726 | 0.140 |
Why?
|
| Mutation | 12 | 2022 | 15917 | 0.140 |
Why?
|
| Melanoma | 4 | 2022 | 5599 | 0.130 |
Why?
|
| DNA, Viral | 1 | 2018 | 748 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 17 | 2 | 2016 | 675 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-met | 2 | 2018 | 426 | 0.130 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2024 | 3929 | 0.130 |
Why?
|
| Centromere | 3 | 2021 | 138 | 0.130 |
Why?
|
| Heterografts | 2 | 2015 | 738 | 0.130 |
Why?
|
| Cell Death | 5 | 2008 | 686 | 0.130 |
Why?
|
| Metaphase | 4 | 2000 | 124 | 0.130 |
Why?
|
| Female | 38 | 2024 | 148885 | 0.120 |
Why?
|
| Cyclooxygenase 2 | 2 | 2008 | 495 | 0.120 |
Why?
|
| ras Proteins | 2 | 2013 | 804 | 0.120 |
Why?
|
| Gene Deletion | 5 | 2017 | 1471 | 0.120 |
Why?
|
| Bone Neoplasms | 6 | 2009 | 2674 | 0.120 |
Why?
|
| Genes, p53 | 5 | 2011 | 1140 | 0.120 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2022 | 1336 | 0.120 |
Why?
|
| RNA-Binding Proteins | 1 | 2020 | 1016 | 0.120 |
Why?
|
| HIV-1 | 1 | 2018 | 636 | 0.110 |
Why?
|
| Glycolysis | 1 | 2017 | 529 | 0.110 |
Why?
|
| Taxoids | 1 | 1997 | 1019 | 0.110 |
Why?
|
| Chromosomes, Human | 3 | 2021 | 288 | 0.110 |
Why?
|
| Monocytes | 2 | 2016 | 784 | 0.110 |
Why?
|
| Colonic Neoplasms | 3 | 2013 | 1435 | 0.110 |
Why?
|
| NF-kappa B | 3 | 2024 | 1555 | 0.110 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2013 | 69 | 0.110 |
Why?
|
| Oxidative Stress | 1 | 2019 | 1152 | 0.110 |
Why?
|
| Methylnitronitrosoguanidine | 2 | 2004 | 14 | 0.110 |
Why?
|
| F-Box Proteins | 1 | 2013 | 96 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2012 | 34 | 0.110 |
Why?
|
| Ultraviolet Rays | 3 | 2004 | 588 | 0.110 |
Why?
|
| Transposases | 1 | 2013 | 68 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-myc | 5 | 2020 | 843 | 0.100 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2013 | 114 | 0.100 |
Why?
|
| Male | 35 | 2020 | 128479 | 0.100 |
Why?
|
| Clonal Evolution | 1 | 2014 | 250 | 0.100 |
Why?
|
| Cell Division | 7 | 2013 | 2657 | 0.100 |
Why?
|
| Lymphoma, Mantle-Cell | 2 | 2009 | 750 | 0.100 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 1998 | 1347 | 0.100 |
Why?
|
| Mice, SCID | 5 | 2017 | 1825 | 0.100 |
Why?
|
| Telomere Homeostasis | 1 | 2012 | 77 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2013 | 329 | 0.100 |
Why?
|
| Nucleotidyltransferases | 2 | 2024 | 96 | 0.100 |
Why?
|
| Hematopoiesis | 1 | 2015 | 600 | 0.100 |
Why?
|
| Transfection | 7 | 2011 | 3109 | 0.100 |
Why?
|
| Adenocarcinoma | 4 | 2016 | 7920 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2015 | 525 | 0.100 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2013 | 237 | 0.090 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2018 | 1235 | 0.090 |
Why?
|
| Radiation Tolerance | 3 | 2017 | 639 | 0.090 |
Why?
|
| Molecular Weight | 3 | 2024 | 714 | 0.090 |
Why?
|
| Neoplasm Metastasis | 7 | 2013 | 5332 | 0.090 |
Why?
|
| Telomeric Repeat Binding Protein 2 | 4 | 2010 | 29 | 0.090 |
Why?
|
| Mice, Transgenic | 6 | 2020 | 4202 | 0.090 |
Why?
|
| Nuclear Proteins | 5 | 2015 | 3435 | 0.090 |
Why?
|
| Cell Differentiation | 4 | 2015 | 4104 | 0.090 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2010 | 376 | 0.090 |
Why?
|
| Werner Syndrome Helicase | 2 | 2007 | 12 | 0.090 |
Why?
|
| Cricetinae | 3 | 2002 | 744 | 0.090 |
Why?
|
| Plant Extracts | 2 | 2003 | 220 | 0.090 |
Why?
|
| Kidney Neoplasms | 2 | 2020 | 3107 | 0.090 |
Why?
|
| Telomeric Repeat Binding Protein 1 | 1 | 2009 | 12 | 0.090 |
Why?
|
| Anoikis | 2 | 2007 | 63 | 0.080 |
Why?
|
| Antigens, CD19 | 1 | 2013 | 585 | 0.080 |
Why?
|
| Hedgehog Proteins | 1 | 2012 | 440 | 0.080 |
Why?
|
| Noscapine | 1 | 2009 | 1 | 0.080 |
Why?
|
| Blast Crisis | 1 | 2012 | 588 | 0.080 |
Why?
|
| Thiolester Hydrolases | 1 | 2009 | 35 | 0.080 |
Why?
|
| Carcinoma | 4 | 2009 | 2610 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2013 | 809 | 0.080 |
Why?
|
| Epigenesis, Genetic | 2 | 2013 | 1439 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 884 | 0.080 |
Why?
|
| DNA Probes | 2 | 1999 | 244 | 0.080 |
Why?
|
| HIV Infections | 2 | 2018 | 2155 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase 2 | 3 | 2022 | 252 | 0.080 |
Why?
|
| Meiosis | 1 | 2010 | 175 | 0.080 |
Why?
|
| Smoke | 1 | 2009 | 60 | 0.080 |
Why?
|
| Haploidy | 1 | 2008 | 43 | 0.080 |
Why?
|
| Blotting, Southern | 2 | 1999 | 453 | 0.080 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2009 | 111 | 0.080 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2012 | 485 | 0.080 |
Why?
|
| Disease Progression | 5 | 2016 | 6881 | 0.080 |
Why?
|
| Fibroblast Growth Factor 9 | 1 | 2008 | 20 | 0.080 |
Why?
|
| Stem Cells | 2 | 2008 | 1211 | 0.080 |
Why?
|
| Aging | 3 | 2007 | 1531 | 0.080 |
Why?
|
| Dyskeratosis Congenita | 1 | 2008 | 26 | 0.080 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 3 | 2021 | 437 | 0.080 |
Why?
|
| beta-Transducin Repeat-Containing Proteins | 1 | 2008 | 41 | 0.080 |
Why?
|
| Cell Fusion | 1 | 2008 | 77 | 0.080 |
Why?
|
| Lymphoma, B-Cell | 1 | 2015 | 930 | 0.080 |
Why?
|
| Cyclins | 3 | 2004 | 465 | 0.080 |
Why?
|
| Models, Biological | 3 | 2021 | 3186 | 0.080 |
Why?
|
| Disease Models, Animal | 6 | 2015 | 7317 | 0.070 |
Why?
|
| Phenotype | 8 | 2009 | 6502 | 0.070 |
Why?
|
| X-Rays | 2 | 2006 | 151 | 0.070 |
Why?
|
| Blotting, Western | 6 | 2012 | 3568 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2011 | 5056 | 0.070 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2012 | 1145 | 0.070 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 5145 | 0.070 |
Why?
|
| Oncogenes | 2 | 2022 | 697 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2012 | 2051 | 0.070 |
Why?
|
| Ovarian Neoplasms | 3 | 2013 | 4809 | 0.070 |
Why?
|
| Exodeoxyribonucleases | 1 | 2007 | 109 | 0.070 |
Why?
|
| Osteogenesis | 1 | 2008 | 271 | 0.070 |
Why?
|
| Neoplasm Invasiveness | 4 | 2016 | 4054 | 0.070 |
Why?
|
| Cell Survival | 3 | 2011 | 3057 | 0.070 |
Why?
|
| Genes, cdc | 1 | 2006 | 84 | 0.070 |
Why?
|
| Histones | 1 | 2013 | 1512 | 0.070 |
Why?
|
| Transcription Factors | 2 | 2012 | 5415 | 0.070 |
Why?
|
| Drug Synergism | 2 | 2024 | 1355 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2012 | 1704 | 0.060 |
Why?
|
| Chromatids | 1 | 2005 | 84 | 0.060 |
Why?
|
| Calcium-Binding Proteins | 1 | 2008 | 542 | 0.060 |
Why?
|
| Mice, Knockout | 6 | 2012 | 5692 | 0.060 |
Why?
|
| Bone and Bones | 1 | 2008 | 605 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 4 | 2015 | 2419 | 0.060 |
Why?
|
| Intestinal Mucosa | 2 | 2021 | 1111 | 0.060 |
Why?
|
| Immunohistochemistry | 5 | 2018 | 7648 | 0.060 |
Why?
|
| Genomics | 3 | 2021 | 2832 | 0.060 |
Why?
|
| Receptor, Adenosine A3 | 2 | 2001 | 7 | 0.060 |
Why?
|
| Ruta | 1 | 2003 | 1 | 0.060 |
Why?
|
| Pancreatic Neoplasms | 1 | 2021 | 5258 | 0.060 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2007 | 551 | 0.060 |
Why?
|
| Sister Chromatid Exchange | 2 | 2006 | 45 | 0.060 |
Why?
|
| Loss of Heterozygosity | 2 | 2021 | 623 | 0.060 |
Why?
|
| Hematologic Neoplasms | 1 | 2015 | 1956 | 0.060 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2004 | 110 | 0.060 |
Why?
|
| Chromosome Mapping | 3 | 2003 | 1648 | 0.060 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2004 | 101 | 0.060 |
Why?
|
| Prostate-Specific Antigen | 3 | 2019 | 1030 | 0.060 |
Why?
|
| Proteins | 2 | 2021 | 2030 | 0.050 |
Why?
|
| Genes, bcl-2 | 2 | 2002 | 172 | 0.050 |
Why?
|
| Carcinogenesis | 2 | 2020 | 1034 | 0.050 |
Why?
|
| Zona Reticularis | 1 | 2022 | 1 | 0.050 |
Why?
|
| Genistein | 1 | 2003 | 74 | 0.050 |
Why?
|
| Estradiol | 2 | 2004 | 828 | 0.050 |
Why?
|
| HCT116 Cells | 1 | 2004 | 354 | 0.050 |
Why?
|
| DNA Methylation | 1 | 2013 | 2768 | 0.050 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2013 | 1854 | 0.050 |
Why?
|
| Receptors, Androgen | 1 | 2008 | 854 | 0.050 |
Why?
|
| DNA Helicases | 1 | 2005 | 459 | 0.050 |
Why?
|
| Lung Neoplasms | 5 | 2013 | 12039 | 0.050 |
Why?
|
| Chromatin | 2 | 2024 | 1043 | 0.050 |
Why?
|
| Gene Expression | 3 | 2006 | 3606 | 0.050 |
Why?
|
| Microtubules | 1 | 2004 | 328 | 0.050 |
Why?
|
| Cell Communication | 2 | 2019 | 509 | 0.050 |
Why?
|
| Interferons | 1 | 2024 | 297 | 0.050 |
Why?
|
| DNA Fragmentation | 2 | 2000 | 205 | 0.050 |
Why?
|
| Sphingosine | 1 | 2002 | 59 | 0.050 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2002 | 59 | 0.050 |
Why?
|
| Drug Resistance, Multiple | 1 | 2002 | 221 | 0.050 |
Why?
|
| Membrane Proteins | 2 | 2024 | 2922 | 0.050 |
Why?
|
| Camptothecin | 1 | 2024 | 540 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 1407 | 0.050 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2006 | 527 | 0.050 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2015 | 3155 | 0.050 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2012 | 1740 | 0.050 |
Why?
|
| Antineoplastic Agents, Alkylating | 2 | 2002 | 605 | 0.050 |
Why?
|
| Retinoblastoma Protein | 1 | 2003 | 339 | 0.050 |
Why?
|
| Single Molecule Imaging | 1 | 2021 | 9 | 0.050 |
Why?
|
| Aurora Kinases | 2 | 2013 | 193 | 0.050 |
Why?
|
| Ethanol | 1 | 2003 | 272 | 0.050 |
Why?
|
| Diploidy | 1 | 2001 | 116 | 0.050 |
Why?
|
| Interleukin-18 | 1 | 2021 | 91 | 0.050 |
Why?
|
| Cell Nucleolus | 1 | 2021 | 101 | 0.050 |
Why?
|
| Mouth Neoplasms | 1 | 2006 | 735 | 0.050 |
Why?
|
| Gene Silencing | 3 | 2010 | 825 | 0.050 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2012 | 2636 | 0.050 |
Why?
|
| Zebrafish Proteins | 1 | 2002 | 154 | 0.050 |
Why?
|
| Base Sequence | 3 | 2021 | 5405 | 0.050 |
Why?
|
| Lymphocytes | 2 | 2003 | 1273 | 0.050 |
Why?
|
| Purinergic P1 Receptor Antagonists | 1 | 2000 | 5 | 0.050 |
Why?
|
| Swine Diseases | 1 | 2000 | 49 | 0.050 |
Why?
|
| Azoxymethane | 1 | 2020 | 44 | 0.050 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2003 | 402 | 0.050 |
Why?
|
| Cardenolides | 1 | 2000 | 24 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2018 | 4644 | 0.040 |
Why?
|
| Aurora Kinase B | 1 | 2020 | 67 | 0.040 |
Why?
|
| Dextrans | 1 | 2020 | 96 | 0.040 |
Why?
|
| Aurora Kinase A | 2 | 2013 | 209 | 0.040 |
Why?
|
| Antineoplastic Agents | 5 | 2009 | 14638 | 0.040 |
Why?
|
| Tumor Protein p73 | 2 | 2015 | 114 | 0.040 |
Why?
|
| Mutation Rate | 1 | 2021 | 220 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2013 | 3945 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2013 | 5582 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2012 | 3582 | 0.040 |
Why?
|
| Protein Binding | 3 | 2018 | 3472 | 0.040 |
Why?
|
| Prostatectomy | 2 | 2019 | 1003 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2008 | 1716 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2020 | 197 | 0.040 |
Why?
|
| Models, Genetic | 2 | 2021 | 1161 | 0.040 |
Why?
|
| G2 Phase | 3 | 2008 | 218 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2022 | 4965 | 0.040 |
Why?
|
| Animal Population Groups | 1 | 1999 | 3 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2005 | 1196 | 0.040 |
Why?
|
| Tartrate-Resistant Acid Phosphatase | 1 | 2019 | 11 | 0.040 |
Why?
|
| Cathepsin K | 1 | 2019 | 15 | 0.040 |
Why?
|
| Signal Transduction | 6 | 2020 | 12042 | 0.040 |
Why?
|
| Micronucleus Tests | 1 | 1999 | 19 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2022 | 562 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2018 | 659 | 0.040 |
Why?
|
| Genotype | 3 | 2002 | 4248 | 0.040 |
Why?
|
| Mice, Mutant Strains | 3 | 2005 | 650 | 0.040 |
Why?
|
| Spheroids, Cellular | 1 | 2019 | 220 | 0.040 |
Why?
|
| Micronuclei, Chromosome-Defective | 1 | 1999 | 32 | 0.040 |
Why?
|
| Kallikreins | 1 | 2019 | 86 | 0.040 |
Why?
|
| DNA Mutational Analysis | 2 | 2021 | 2356 | 0.040 |
Why?
|
| Plant Lectins | 1 | 1998 | 23 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2006 | 1581 | 0.040 |
Why?
|
| Enzyme Inhibitors | 3 | 2004 | 1944 | 0.040 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 1998 | 49 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 2019 | 426 | 0.040 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2022 | 617 | 0.040 |
Why?
|
| Plant Preparations | 1 | 1998 | 29 | 0.040 |
Why?
|
| Calreticulin | 1 | 2019 | 84 | 0.040 |
Why?
|
| CHO Cells | 1 | 1999 | 320 | 0.040 |
Why?
|
| Orchiectomy | 2 | 2009 | 211 | 0.040 |
Why?
|
| Heredity | 1 | 2018 | 26 | 0.040 |
Why?
|
| Spindle Apparatus | 2 | 2009 | 113 | 0.040 |
Why?
|
| Lectins | 1 | 1998 | 145 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 2 | 2012 | 1188 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2004 | 538 | 0.040 |
Why?
|
| Chromosome Inversion | 1 | 1999 | 197 | 0.040 |
Why?
|
| Toxins, Biological | 1 | 1998 | 70 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2016 | 1276 | 0.040 |
Why?
|
| Rodentia | 1 | 1998 | 61 | 0.040 |
Why?
|
| Caspase 3 | 3 | 2004 | 460 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2020 | 2363 | 0.040 |
Why?
|
| Plant Proteins | 1 | 1998 | 133 | 0.040 |
Why?
|
| Polyglutamic Acid | 1 | 1997 | 49 | 0.040 |
Why?
|
| Osteosarcoma | 2 | 2008 | 951 | 0.040 |
Why?
|
| Adult | 8 | 2024 | 82041 | 0.040 |
Why?
|
| RNA Editing | 1 | 2018 | 97 | 0.040 |
Why?
|
| Organoids | 1 | 2020 | 329 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 1999 | 354 | 0.040 |
Why?
|
| Middle Aged | 8 | 2024 | 90533 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 1072 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 1998 | 275 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2003 | 1310 | 0.040 |
Why?
|
| Tumor Microenvironment | 2 | 2024 | 3054 | 0.040 |
Why?
|
| Cyclin B1 | 2 | 2009 | 60 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2024 | 1837 | 0.040 |
Why?
|
| Embryo, Mammalian | 2 | 2012 | 744 | 0.030 |
Why?
|
| Rats | 2 | 2000 | 6397 | 0.030 |
Why?
|
| Cyclin B | 2 | 2009 | 69 | 0.030 |
Why?
|
| Doxorubicin | 3 | 2011 | 3145 | 0.030 |
Why?
|
| Survival Analysis | 4 | 2015 | 9281 | 0.030 |
Why?
|
| Time Factors | 4 | 2011 | 12978 | 0.030 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2016 | 230 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2024 | 4907 | 0.030 |
Why?
|
| Colon | 1 | 2020 | 684 | 0.030 |
Why?
|
| Serum Amyloid P-Component | 1 | 2016 | 31 | 0.030 |
Why?
|
| Homeodomain Proteins | 2 | 2016 | 1124 | 0.030 |
Why?
|
| Gonadal Dysgenesis | 1 | 1996 | 4 | 0.030 |
Why?
|
| RNA, Neoplasm | 2 | 2013 | 805 | 0.030 |
Why?
|
| Bone Marrow Cells | 3 | 2008 | 965 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2017 | 221 | 0.030 |
Why?
|
| DNA End-Joining Repair | 1 | 2017 | 92 | 0.030 |
Why?
|
| Organ Specificity | 2 | 2008 | 734 | 0.030 |
Why?
|
| Selection, Genetic | 1 | 2017 | 196 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2018 | 302 | 0.030 |
Why?
|
| RNA, Messenger | 3 | 2013 | 6344 | 0.030 |
Why?
|
| Prognosis | 4 | 2020 | 22528 | 0.030 |
Why?
|
| Genitalia, Male | 1 | 1996 | 46 | 0.030 |
Why?
|
| Osteoblasts | 2 | 2008 | 398 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2003 | 2618 | 0.030 |
Why?
|
| Cryptorchidism | 1 | 1996 | 49 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2013 | 1135 | 0.030 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2015 | 28 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2020 | 9463 | 0.030 |
Why?
|
| India | 1 | 1996 | 311 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 2 | 2010 | 526 | 0.030 |
Why?
|
| Skin | 1 | 2001 | 1281 | 0.030 |
Why?
|
| Oligopeptides | 1 | 1998 | 450 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2017 | 687 | 0.030 |
Why?
|
| Genes, myc | 1 | 1997 | 372 | 0.030 |
Why?
|
| Skin Neoplasms | 3 | 2007 | 4899 | 0.030 |
Why?
|
| Serine-Arginine Splicing Factors | 1 | 2015 | 84 | 0.030 |
Why?
|
| Age Factors | 1 | 2024 | 5441 | 0.030 |
Why?
|
| Genetic Therapy | 1 | 2003 | 1715 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2017 | 341 | 0.030 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2019 | 521 | 0.030 |
Why?
|
| Cell Movement | 2 | 2016 | 2468 | 0.030 |
Why?
|
| ErbB Receptors | 2 | 2019 | 2376 | 0.030 |
Why?
|
| Glycoproteins | 1 | 1998 | 775 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 267 | 0.030 |
Why?
|
| Virus Replication | 1 | 2018 | 762 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 2016 | 2986 | 0.030 |
Why?
|
| Myeloproliferative Disorders | 1 | 2002 | 882 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2015 | 298 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2016 | 6257 | 0.030 |
Why?
|
| Pyrimidines | 2 | 2017 | 3671 | 0.030 |
Why?
|
| DNA Fingerprinting | 1 | 2014 | 180 | 0.030 |
Why?
|
| Dual Specificity Phosphatase 3 | 1 | 2013 | 8 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2001 | 1691 | 0.030 |
Why?
|
| Janus Kinase 2 | 1 | 2019 | 755 | 0.030 |
Why?
|
| Cytarabine | 1 | 2000 | 2014 | 0.030 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 2 | 2008 | 192 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2015 | 398 | 0.030 |
Why?
|
| Coculture Techniques | 2 | 2008 | 626 | 0.030 |
Why?
|
| Dose-Response Relationship, Radiation | 2 | 2006 | 751 | 0.030 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2005 | 1831 | 0.030 |
Why?
|
| Transcription Factor 7-Like 1 Protein | 1 | 2013 | 30 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2015 | 362 | 0.030 |
Why?
|
| Fibrosis | 1 | 2016 | 715 | 0.030 |
Why?
|
| Staurosporine | 2 | 2004 | 147 | 0.030 |
Why?
|
| G1 Phase | 2 | 2004 | 306 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 3 | 2007 | 3464 | 0.030 |
Why?
|
| Protein Isoforms | 2 | 2006 | 843 | 0.030 |
Why?
|
| Cytokinesis | 1 | 2013 | 57 | 0.030 |
Why?
|
| Genome, Human | 1 | 2021 | 1896 | 0.030 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2008 | 741 | 0.030 |
Why?
|
| Alkyl and Aryl Transferases | 1 | 2013 | 91 | 0.030 |
Why?
|
| Smoothened Receptor | 1 | 2012 | 53 | 0.030 |
Why?
|
| Cell Size | 1 | 2012 | 140 | 0.030 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2013 | 155 | 0.030 |
Why?
|
| Electroporation | 1 | 2013 | 127 | 0.030 |
Why?
|
| K562 Cells | 1 | 2012 | 344 | 0.030 |
Why?
|
| Zinc Finger Protein GLI1 | 1 | 2012 | 115 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2006 | 5604 | 0.020 |
Why?
|
| Gene Rearrangement | 2 | 2007 | 809 | 0.020 |
Why?
|
| Methylation | 1 | 2013 | 625 | 0.020 |
Why?
|
| CD3 Complex | 1 | 2013 | 320 | 0.020 |
Why?
|
| Hydrogen Peroxide | 2 | 2003 | 218 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 590 | 0.020 |
Why?
|
| Nitriles | 1 | 2016 | 939 | 0.020 |
Why?
|
| Aged | 4 | 2024 | 73613 | 0.020 |
Why?
|
| Flow Cytometry | 3 | 2003 | 3040 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2016 | 2087 | 0.020 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 2011 | 67 | 0.020 |
Why?
|
| Genes, Immunoglobulin Heavy Chain | 1 | 2011 | 37 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2011 | 257 | 0.020 |
Why?
|
| Chromosomes, Mammalian | 1 | 2011 | 62 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2015 | 4007 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2022 | 10404 | 0.020 |
Why?
|
| Transcription, Genetic | 2 | 2013 | 3328 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 1998 | 1656 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2013 | 896 | 0.020 |
Why?
|
| Tumor Suppressor p53-Binding Protein 1 | 1 | 2010 | 88 | 0.020 |
Why?
|
| Ku Autoantigen | 1 | 2010 | 82 | 0.020 |
Why?
|
| Wnt Signaling Pathway | 1 | 2013 | 443 | 0.020 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2003 | 2435 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 1996 | 1023 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2014 | 799 | 0.020 |
Why?
|
| Algorithms | 1 | 2021 | 3906 | 0.020 |
Why?
|
| Antigens, Nuclear | 1 | 2010 | 126 | 0.020 |
Why?
|
| Purines | 1 | 2011 | 271 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2005 | 1127 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2013 | 800 | 0.020 |
Why?
|
| Thymus Gland | 1 | 2011 | 309 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 31116 | 0.020 |
Why?
|
| Trans-Activators | 2 | 2006 | 1626 | 0.020 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2012 | 327 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 3 | 2007 | 7052 | 0.020 |
Why?
|
| RNA Interference | 1 | 2013 | 1381 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2009 | 210 | 0.020 |
Why?
|
| Hematopoietic System | 1 | 2008 | 26 | 0.020 |
Why?
|
| ADP-ribosyl Cyclase 1 | 1 | 2009 | 149 | 0.020 |
Why?
|
| S Phase | 1 | 2009 | 289 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2016 | 2440 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 1195 | 0.020 |
Why?
|
| Protein Stability | 1 | 2009 | 375 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2008 | 336 | 0.020 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2008 | 40 | 0.020 |
Why?
|
| Mad2 Proteins | 1 | 2008 | 33 | 0.020 |
Why?
|
| Leukemia | 1 | 1997 | 1719 | 0.020 |
Why?
|
| Proteasome Inhibitors | 1 | 2009 | 235 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2015 | 2177 | 0.020 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2009 | 225 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2008 | 228 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 2008 | 253 | 0.020 |
Why?
|
| Mammary Glands, Human | 1 | 2009 | 182 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2008 | 306 | 0.020 |
Why?
|
| Chemokines | 1 | 2008 | 285 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 2008 | 246 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2009 | 639 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2016 | 1551 | 0.020 |
Why?
|
| Keratins | 1 | 2008 | 340 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2013 | 1624 | 0.020 |
Why?
|
| Vimentin | 1 | 2008 | 252 | 0.020 |
Why?
|
| Adolescent | 2 | 2013 | 32689 | 0.020 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2007 | 128 | 0.020 |
Why?
|
| Papilloma | 1 | 2007 | 86 | 0.020 |
Why?
|
| Receptors, Interleukin | 1 | 2007 | 97 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2007 | 437 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 2560 | 0.020 |
Why?
|
| Sequence Homology | 1 | 2006 | 76 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2008 | 931 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 3205 | 0.020 |
Why?
|
| Checkpoint Kinase 1 | 1 | 2007 | 169 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 2011 | 1057 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2014 | 2157 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2007 | 286 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2008 | 523 | 0.020 |
Why?
|
| Environment | 1 | 2006 | 170 | 0.020 |
Why?
|
| Genetic Markers | 2 | 1999 | 1073 | 0.020 |
Why?
|
| Oncogene Proteins v-erbB | 1 | 2005 | 4 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 2008 | 4105 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 2007 | 440 | 0.020 |
Why?
|
| Centrosome | 1 | 2005 | 106 | 0.020 |
Why?
|
| Calcimycin | 1 | 2004 | 52 | 0.020 |
Why?
|
| Ionophores | 1 | 2004 | 23 | 0.010 |
Why?
|
| Cytochromes c | 1 | 2004 | 116 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2006 | 1044 | 0.010 |
Why?
|
| Aging, Premature | 1 | 2004 | 39 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2005 | 556 | 0.010 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 2004 | 38 | 0.010 |
Why?
|
| Caspase 8 | 1 | 2004 | 146 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2007 | 690 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 16741 | 0.010 |
Why?
|
| Life Expectancy | 1 | 2004 | 129 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2006 | 1023 | 0.010 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 2004 | 131 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2008 | 1004 | 0.010 |
Why?
|
| Integrases | 1 | 2005 | 254 | 0.010 |
Why?
|
| Stomach Neoplasms | 1 | 1996 | 2339 | 0.010 |
Why?
|
| Ploidies | 1 | 2003 | 250 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2013 | 6233 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2006 | 908 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 10268 | 0.010 |
Why?
|
| Gene Dosage | 1 | 2006 | 822 | 0.010 |
Why?
|
| Models, Chemical | 1 | 2003 | 177 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2004 | 300 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1996 | 8603 | 0.010 |
Why?
|
| HL-60 Cells | 1 | 2003 | 318 | 0.010 |
Why?
|
| Caspase Inhibitors | 1 | 2003 | 95 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2004 | 443 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 2003 | 404 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2007 | 889 | 0.010 |
Why?
|
| Endometrial Neoplasms | 1 | 2012 | 1386 | 0.010 |
Why?
|
| Drug Resistance | 1 | 2004 | 608 | 0.010 |
Why?
|
| Cricetulus | 1 | 2002 | 214 | 0.010 |
Why?
|
| Alkylation | 1 | 2002 | 32 | 0.010 |
Why?
|
| NADP | 1 | 2002 | 88 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2008 | 2413 | 0.010 |
Why?
|
| Cadherins | 1 | 2005 | 659 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2015 | 5246 | 0.010 |
Why?
|
| Bone Resorption | 1 | 2002 | 137 | 0.010 |
Why?
|
| Tibia | 1 | 2002 | 131 | 0.010 |
Why?
|
| Cell Separation | 1 | 2003 | 606 | 0.010 |
Why?
|
| Metribolone | 1 | 2001 | 47 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2002 | 374 | 0.010 |
Why?
|
| Inbreeding | 1 | 2000 | 13 | 0.010 |
Why?
|
| Urothelium | 1 | 2003 | 264 | 0.010 |
Why?
|
| Rotation | 1 | 2001 | 98 | 0.010 |
Why?
|
| Swine, Miniature | 1 | 2000 | 70 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2003 | 660 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2004 | 1801 | 0.010 |
Why?
|
| Remission, Spontaneous | 1 | 2000 | 125 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2007 | 1420 | 0.010 |
Why?
|
| Hyperplasia | 1 | 2002 | 571 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 2478 | 0.010 |
Why?
|
| Precancerous Conditions | 1 | 2007 | 1061 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 4532 | 0.010 |
Why?
|
| Genes, ras | 1 | 2003 | 678 | 0.010 |
Why?
|
| Microspheres | 1 | 2001 | 235 | 0.010 |
Why?
|
| Plants | 1 | 2000 | 64 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 2002 | 414 | 0.010 |
Why?
|
| Growth Substances | 1 | 2001 | 325 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2013 | 2882 | 0.010 |
Why?
|
| Nevus, Pigmented | 1 | 2000 | 117 | 0.010 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2001 | 425 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2009 | 4969 | 0.010 |
Why?
|
| Wnt Proteins | 1 | 2002 | 383 | 0.010 |
Why?
|
| Wound Healing | 1 | 2004 | 771 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 6639 | 0.010 |
Why?
|
| Ribosome Inactivating Proteins, Type 2 | 1 | 1998 | 2 | 0.010 |
Why?
|
| Ribosome Inactivating Proteins | 1 | 1998 | 3 | 0.010 |
Why?
|
| DNA Restriction Enzymes | 1 | 1998 | 161 | 0.010 |
Why?
|
| Dogs | 1 | 2000 | 1082 | 0.010 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2001 | 770 | 0.010 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2005 | 1404 | 0.010 |
Why?
|
| Models, Animal | 1 | 2000 | 657 | 0.010 |
Why?
|
| Adenoviruses, Human | 1 | 1998 | 191 | 0.010 |
Why?
|
| Depsipeptides | 1 | 1998 | 77 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2001 | 1592 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2003 | 1837 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2003 | 1490 | 0.010 |
Why?
|
| Mitochondria | 1 | 2004 | 1292 | 0.010 |
Why?
|
| Abdominal Neoplasms | 1 | 1999 | 251 | 0.010 |
Why?
|
| Swine | 1 | 2000 | 1513 | 0.010 |
Why?
|
| Proto-Oncogenes | 1 | 1996 | 208 | 0.010 |
Why?
|
| DNA Primers | 1 | 1998 | 1489 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 1996 | 234 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 5157 | 0.010 |
Why?
|
| Kinetics | 1 | 1998 | 2206 | 0.010 |
Why?
|
| X Chromosome | 1 | 1996 | 400 | 0.010 |
Why?
|
| Carcinoma, Signet Ring Cell | 1 | 1996 | 180 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 1996 | 324 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 1996 | 413 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2004 | 1417 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 2001 | 3245 | 0.010 |
Why?
|
| Cytokines | 1 | 2002 | 2803 | 0.010 |
Why?
|
| Testis | 1 | 1996 | 620 | 0.010 |
Why?
|
| Fluorouracil | 1 | 1997 | 1990 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2002 | 6193 | 0.010 |
Why?
|
| Biopsy | 1 | 1996 | 3490 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 1996 | 14033 | 0.000 |
Why?
|